The Glow Complex is a tri-peptide research formulation combining GHK-Cu, BPC-157, and TB-500. Because it is a blend, its dosing is understood as the combined protocol of its three constituents, each contributing a complementary tissue-repair and skin-research mechanism.
Standard Research Dosage
As a reconstituted blend, common research protocols deliver the constituent doses together: GHK-Cu ~1–2 mg, BPC-157 ~250–500 mcg, and TB-500 ~2–2.5 mg per administration, typically subcutaneously. The exact per-vial ratio depends on the specific formulation supplied.
Administration and Timing
The Glow Complex is administered subcutaneously, often into abdominal fat for systemic effect or near a target site for localized skin/tissue research. Dosing frequency follows the slowest-clearing constituent — TB-500's longer half-life means 2–3x weekly dosing is common rather than daily.
Constituent Mechanisms
GHK-Cu drives collagen and elastin synthesis and matrix remodeling; BPC-157 promotes angiogenesis and growth-factor signaling; TB-500 supports actin-mediated cell migration and systemic repair. The rationale for the blend is that the three mechanisms are non-overlapping and potentially synergistic.
Cycle Length
Research protocols typically run 4–8 weeks for skin and tissue-repair studies. Because direct studies on this specific three-way combination are limited, cycle design is extrapolated from the individual constituent literature.